Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

about

Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic

P2860

Q58545262-D962C4A5-7C10-4B32-B1D0-962BF5333050

P2860

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

Item

http://www.wikidata.org/entity/Q44349177

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

@en

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

@nl

type

Item

label

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

@en

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

@nl

prefLabel

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

@en

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

@nl

P1476

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

@en

P2093

Babette Y Kögel

http://www.w3.org/2001/XMLSchema#string

Klaus Linz

http://www.w3.org/2001/XMLSchema#string

Stefanie Frosch

http://www.w3.org/2001/XMLSchema#string

P2860

Neurobiology of opioid dependence in creating addiction vulnerability

The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications

Orphanin FQ/nociceptin inhibits morphine withdrawal

Antinociceptive potentiation and attenuation of tolerance by intrathecal β-arrestin 2 small interfering RNA in rats

A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine

Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence.

Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.

Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol.

Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats.

The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats.

P304

1010-1019

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ADB.12550

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas M Tzschentke

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28944554

http://www.w3.org/2001/XMLSchema#string

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

about

P2860

P2860

Limited potential of cebranopadol to produce opioid-type physical dependence in rodents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698